- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/58 - Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
Patent holdings for IPC class G01N 33/58
Total number of patents in this class: 6075
10-year publication summary
431
|
439
|
523
|
570
|
466
|
519
|
497
|
513
|
516
|
163
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 18943 |
99 |
Life Technologies Corporation | 3068 |
85 |
Ventana Medical Systems, Inc. | 972 |
81 |
Becton, Dickinson and Company | 6712 |
74 |
Promega Corporation | 548 |
66 |
Centre National de La Recherche Scientifique | 9632 |
63 |
Massachusetts Institute of Technology | 9795 |
56 |
F. Hoffmann-La Roche AG | 7958 |
48 |
Bio-Rad Laboratories, Inc. | 1592 |
39 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
37 |
President and Fellows of Harvard College | 5792 |
37 |
Board of Regents, The University of Texas System | 5370 |
36 |
10X Genomics, Inc. | 921 |
34 |
Purdue Research Foundation | 3277 |
33 |
Siemens Healthcare Diagnostics Inc. | 1946 |
32 |
Roche Diagnostics Operations, Inc. | 1375 |
31 |
Agilent Technologies, Inc. | 2744 |
31 |
The General Hospital Corporation | 4517 |
29 |
Konica Minolta, Inc. | 8349 |
28 |
Pacific Biosciences of California, Inc. | 738 |
28 |
Other owners | 5108 |